微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 13.75% | 4.64% | 49.62% | 12/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 9.19% | 66.49% | 192.68% | 11/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.14% | 16.3% | -78.4% | 27/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 14.54% | 10.74% | 10.65% | 11/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 13.14% | 11.54% | 138.04% | 8/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.52% | -23.55% | 104.44% | 33/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.7% | 0.75% | -79.44% | 43/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 13.13% | 15.89% | 11.46% | 26/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 11.78% | 26.8% | 63.16% | 22/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 7.22% | 31.27% | 169.4% | 26/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.68% | 15.52% | -76.35% | 45/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 11.33% | -17.96% | 21.96% | 38/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 9.29% | -32.09% | 68.91% | 38/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.5% | -44.28% | 137.07% | 50/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.32% | 2% | -83.2% | 62/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 13.81% | -16.56% | 0.95% | 36/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 13.68% | 2% | 38.6% | 22/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 9.87% | 16.8% | -40.36% | 20/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2019-12-31 | 16.55% | -7.39% | 95.86% | 30/160 | 2.78% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-06-30 | 8.45% | 2% | -52.71% | 24/160 | 5.05% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-12-31 | 17.87% | -4.44% | -4.44% | 25/160 | 7.09% | 奥赛康 | 35% | 行业排名> |
| 2017-12-31 | 18.7% | 2% | 2% | 15/160 | 9.66% | 奥赛康 | 28.15% | 行业排名> |